Moderna Seeks FDA Approval for Enhanced Covid Vaccine Targeting Fall Season
A vial and a medical syringe seen displayed in front of the U.S. Food and Drug Administration and Moderna biotechnology company’s logos. Pavlo Gonchar | LightRocket | Getty Images Moderna has officially submitted its updated Covid vaccine for FDA approval. The biotech company is targeting the omicron subvariant XBB.1.5, which is currently the dominant strain …